Vontobel Financial Products GmbH Share Price

Certificat

DE000VE54UE0

Market Closed - Deutsche Boerse AG 11:25:05 28/06/2024 pm IST
94.12 EUR -0.66% Intraday chart for Vontobel Financial Products GmbH
Current month+6.13%
1 month+7.00%
Date Price Change
28/24/28 94.12 -0.66%
27/24/27 94.75 +0.23%
26/24/26 94.53 -0.78%
25/24/25 95.27 -0.10%
24/24/24 95.37 +0.40%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:25 pm IST

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VE54UE
ISINDE000VE54UE0
Date issued 17/01/2020
Strike 244.6 CHF
Maturity 17/01/2025 (202 Days)
Parity 0.24 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 102.4
Lowest since issue 74.19

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus